Measles

Many individuals with cancer lack adequate immune defense against the measles and mumps viruses, according to a study conducted by researchers at Fred Hutchinson Cancer Research Center and published in JAMA Network Open.

Although pediatric measles vaccine coverage has largely improved globally over the past decade, more than half of low- and middle-income countries included in a study published in Nature experienced slowed progress, researchers reported.

Researchers from WHO and the CDC reported that measles cases reached a 23-year high in 2019. It was the top story in infectious disease last week.

Globally, more than 207,000 people died from measles in 2019 as the number of cases of the highly contagious but preventable disease reached a 23-year high, researchers from WHO and the CDC reported.

This episode explores how we began to measure antibody levels and how serotherapy was used to investigate multiple diseases. We’ll also learn how advances in laboratory techniques paved the way for a better understanding of the antibody.

Researchers used county-level vaccination data and a model that distributed arriving travelers to counties near international airports to estimate the U.S. counties — and international travel routes — at highest risk for measles outbreaks.

The Global Vaccine Summit, hosted virtually this week by the government of the United Kingdom, raised $8.8 billion in funding for programs to vaccinate 300 million children by 2025, according to Gavi, the Vaccine Alliance.

U.S. President Donald J. Trump announced last week that the U.S. would withdraw from WHO, citing criticism of its response to the COVID-19 pandemic and its relationship with China.

At least 80 million children aged younger than 1 year could miss routine vaccinations because of the COVID-19 pandemic, WHO and other groups warned today.

According to the data from the CDC, 70% of children in the United States aged 19 to 35 months receive the combined seven-vaccine series in 2017. In the past 12 months in the U.S., 50% of children aged 6 months to 17 years, 34% of adults aged 18 to 49 years, 47% of adults aged 50 to 64 years and 69% of adults aged 65 years or older received an influenza vaccination.